Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

Standard

Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis. / Janni, Wolfgang; Vogl, Florian D; Wiedswang, Gro; Synnestvedt, Marit; Fehm, Tanja; Jückstock, Julia; Borgen, Elin; Rack, Brigitte; Braun, Stephan; Sommer, Harald; Solomayer, Erich; Pantel, Klaus; Nesland, Jahn; Friese, Klaus; Naume, Bjørn.

in: CLIN CANCER RES, Jahrgang 17, Nr. 9, 9, 2011, S. 2967-2976.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Janni, W, Vogl, FD, Wiedswang, G, Synnestvedt, M, Fehm, T, Jückstock, J, Borgen, E, Rack, B, Braun, S, Sommer, H, Solomayer, E, Pantel, K, Nesland, J, Friese, K & Naume, B 2011, 'Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.', CLIN CANCER RES, Jg. 17, Nr. 9, 9, S. 2967-2976. <http://www.ncbi.nlm.nih.gov/pubmed/21415211?dopt=Citation>

APA

Janni, W., Vogl, F. D., Wiedswang, G., Synnestvedt, M., Fehm, T., Jückstock, J., Borgen, E., Rack, B., Braun, S., Sommer, H., Solomayer, E., Pantel, K., Nesland, J., Friese, K., & Naume, B. (2011). Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis. CLIN CANCER RES, 17(9), 2967-2976. [9]. http://www.ncbi.nlm.nih.gov/pubmed/21415211?dopt=Citation

Vancouver

Bibtex

@article{3eb7ece0ab5f47c886719cbbef68e494,
title = "Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.",
abstract = "The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis has been confirmed by a large pooled analysis. In view of the lack of early indicators for secondary adjuvant treatment, we here evaluated whether the persistence of DTCs after adjuvant therapy increases the risk of subsequent relapse and death.",
keywords = "Biopsy, Humans, Aged, Female, Middle Aged, Risk Factors, Europe, Immunohistochemistry, Predictive Value of Tests, Prognosis, Recurrence, Bone Marrow/*pathology, Neoplastic Cells, Circulating/*pathology, Bone Marrow Neoplasms/etiology/secondary, Breast Neoplasms/*diagnosis/mortality/*pathology, Carcinoma/*diagnosis/mortality/*pathology, Biopsy, Humans, Aged, Female, Middle Aged, Risk Factors, Europe, Immunohistochemistry, Predictive Value of Tests, Prognosis, Recurrence, Bone Marrow/*pathology, Neoplastic Cells, Circulating/*pathology, Bone Marrow Neoplasms/etiology/secondary, Breast Neoplasms/*diagnosis/mortality/*pathology, Carcinoma/*diagnosis/mortality/*pathology",
author = "Wolfgang Janni and Vogl, {Florian D} and Gro Wiedswang and Marit Synnestvedt and Tanja Fehm and Julia J{\"u}ckstock and Elin Borgen and Brigitte Rack and Stephan Braun and Harald Sommer and Erich Solomayer and Klaus Pantel and Jahn Nesland and Klaus Friese and Bj{\o}rn Naume",
year = "2011",
language = "English",
volume = "17",
pages = "2967--2976",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

AU - Janni, Wolfgang

AU - Vogl, Florian D

AU - Wiedswang, Gro

AU - Synnestvedt, Marit

AU - Fehm, Tanja

AU - Jückstock, Julia

AU - Borgen, Elin

AU - Rack, Brigitte

AU - Braun, Stephan

AU - Sommer, Harald

AU - Solomayer, Erich

AU - Pantel, Klaus

AU - Nesland, Jahn

AU - Friese, Klaus

AU - Naume, Bjørn

PY - 2011

Y1 - 2011

N2 - The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis has been confirmed by a large pooled analysis. In view of the lack of early indicators for secondary adjuvant treatment, we here evaluated whether the persistence of DTCs after adjuvant therapy increases the risk of subsequent relapse and death.

AB - The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis has been confirmed by a large pooled analysis. In view of the lack of early indicators for secondary adjuvant treatment, we here evaluated whether the persistence of DTCs after adjuvant therapy increases the risk of subsequent relapse and death.

KW - Biopsy

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Europe

KW - Immunohistochemistry

KW - Predictive Value of Tests

KW - Prognosis

KW - Recurrence

KW - Bone Marrow/pathology

KW - Neoplastic Cells, Circulating/pathology

KW - Bone Marrow Neoplasms/etiology/secondary

KW - Breast Neoplasms/diagnosis/mortality/pathology

KW - Carcinoma/diagnosis/mortality/pathology

KW - Biopsy

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Europe

KW - Immunohistochemistry

KW - Predictive Value of Tests

KW - Prognosis

KW - Recurrence

KW - Bone Marrow/pathology

KW - Neoplastic Cells, Circulating/pathology

KW - Bone Marrow Neoplasms/etiology/secondary

KW - Breast Neoplasms/diagnosis/mortality/pathology

KW - Carcinoma/diagnosis/mortality/pathology

M3 - SCORING: Journal article

VL - 17

SP - 2967

EP - 2976

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 9

M1 - 9

ER -